`
`Seven $1 billion-plus drugs seen reaching market in 2016 | Reuters
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Business | Wed Feb 3, 2016 4:21am EST
`
`Related: HEALTH
`
`Seven $1 billion-plus drugs seen reaching market in 2016
`
`PHOTOS OF THE DAY
`
`IN PHOTOS: VICTORY DAY
`
`Pharmaceutical tablets and capsules in foil strips are arranged on a table, in this file photo illustration shot in Ljubljana
`on September 18, 2013.
`REUTERS/SRDJAN ZIVULOVIC/FILES
`
`Drug companies are likely to launch seven "blockbuster" drugs in 2016, each with $1
`billion-plus annual sales potential, led by new treatments for liver disease and HIV,
`according to a Thomson Reuters analysis.
`
`The assessment means the pharmaceuticals industry is on track for another productive
`year, although not as good as 2015, which saw the arrival of 11 new blockbusters.
`
`The two top hits of 2016 are tipped to be Intercept Pharmaceuticals' (ICPT.O) chronic liver
`disease drug obeticholic acid, with a consensus sales forecast of $2.6 billion in 2020, and
`Gilead Sciences' (GILD.O) new fixed dose HIV drug emtricitabine plus tenofovir
`alafenamide, on $2.0 billion.
`
`Other products expected to launch this year with forecast sales above $1 billion in 2020
`include a new hepatitis C drug from Merck (MRK.N) and a leukemia medicine from AbbVie
`(ABBV.N), according to the annual "Drugs to Watch" report.
`
`Two keenly awaited Roche ROG.VX drugs, each with forecast sales of around $3 billion,
`are not on list because it is unclear if atezolizumab for cancer and ocrelizumab for multiple
`sclerosis will be commercially available this year or next.
`
`(Reporting by Ben Hirschler Editing by Jeremy Gaunt)
`
`Commemorating the former Soviet Union's victory over
`Nazi Germany in World War II. Slideshow »
`
`BUILD YOUR PERFECT CANDIDATE
`
`Download Reuters' White House Run
`from the App Store
`
`http://www.reuters.com/article/us-pharmaceuticals-blockbusters-idUSKCN0VC0CG
`
`SANOFI v. GENENTECH
`IPR2015-01624
`EXHIBIT 2129
`
`1/2
`
`
`
`5/9/2016
`
`Seven $1 billion-plus drugs seen reaching market in 2016 | Reuters
`
`TRENDING ON REUTERS
`
`Trump retreats on comments on raising
`taxes on the wealthy |
`
`North Carolina officials sue Justice
`Department over transgender 'bathroom
`law' |
`
`Brazil Senate moves forward with
`impeachment process
`
`Japanese court rules vagina figurines 'pop
`art', not obscenity |
`
`Russian firm milks chilly US-Kremlin ties
`with 'Little Obama' ice cream
`
`1
`2
`
`3
`4
`5
`
`Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small
`business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson
`Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
`
`NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
`
`http://www.reuters.com/article/us-pharmaceuticals-blockbusters-idUSKCN0VC0CG
`
`2/2
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
